Traduction de «know about the available » (Néerlandais → Français) :

“In the face of this devastating chronic and progressive disease, it is important for AD caregivers to know about the available educational resources, support networks and treatments in order to enhance these discussions at all stages of the disease”.
“In the face of this devastating chronic and progressive disease, it is important for AD caregivers to know about the available educational resources, support networks and treatments in order to enhance these discussions at all stages of the disease ”.

This release contains forward-looking information about an agreement by Pfizer to acquire FoldRx, and about FoldRx’s product candidate tafamidis, its other clinical and preclinical development programs and its technology platform, including their potential benefits, that involves substantial risks and uncertainties. Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments. A further description of risks and uncertainties can be found in Pfizer’s Annual Report on Form 10-K for the fiscal year ended December 31, 2009 and in its reports on Form 10-Q and Form 8-K.
Such risks and uncertainties include, among other things, the satisfaction of conditions to closing the agreement; the uncertainties inherent in research and development; whether and when a new drug application for tafamidis will be filed with the FDA; decisions by regulatory authorities regarding whether and when to approve any drug applications that have been or may be filed for tafamidis and that may be filed for any other product candidates that may be generated by FoldRx’s technology platform as well as their decisions regarding labeling and other matters that could affect the availability or commercial potential of tafamidis and such other product candidates; and competitive developments.

EVERYTHING ONE NEEDS TO KNOW ABOUT social securitY In Belgium
L’essentiel de ce qu’il faut savoir sur la securite sociale en Belgique

With even less input about the callers available than is the case for telephone conversations (there is no way of either seeing or hearing them), the emotional distance between the two persons concerned is even greater and the risk of misunderstanding higher.
Comme on a encore moins d’input sur l’appelant que par téléphone (on ne peut ni le voir ni l’entendre), la distance entre les deux personnes est plus grande sur le plan sentimental et la possibilité de mauvaises interprétations est plus grande.

Based on an evaluation of publicly available information about Alcon during the first half of 2009, no factors indicated that the “value in use” of this strategic investment to Novartis has fallen below the current carrying value of USD 136.84 per share (The revised carrying value from the previous level of USD 140.58 at the end of the first quarter of 2009 takes into account dividends paid in 2009 as well as other equity accounting adjustments).
Sur la base d’une évaluation des informations publiées sur Alcon au cours du premier semestre 2009, aucun facteur n’indiquait que pour Novartis, la valeur d’utilité de cet investissement stratégique était tombée en dessous de la valeur comptable d’USD 136,84 par action (cette valeur comptable inscrite au bilan et révisée par rapport à la valeur d’USD 140,58 à la fin du premier trimestre 2009, suite aux dividendes payés en 2009 ainsi que d’autres ajustements comptables résultant de l’application de la méthode de la mise en équivalence).

The Superior Health Council takes due note of the fact that the European Authorities have made available re-assuring data about the innocuousness of two of the main ingredients of energy drinks, namely taurine and D-glucuronolactone.
Le Conseil Supérieur de la Santé prend acte de la mise à disposition par les autorités européennes de données rassurantes sur l’innocuité de deux principaux composants des boissons énergisantes, à savoir la taurine et la D-glucuronolactone.

To learn more about our commitments, please visit us at www.pfizer.com. More information is available at www.pfizer.com.
To learn more about our commitments, please visit us at www.pfizer.com .More information is available at www.pfizer.com.

Information about sample availability e-mail ech_staal@fagg-afmps.be
Information about sample availability e-mail ech_staal@fagg-afmps.be

Written procedures about the precautions to be taken during visits and/or examinations carried out on patients carrying MRSA must be available.
Des procédures écrites concernant les précautions à prendre au cours des visites et/ou des examens effectués sur des patients porteurs de MRSA doivent être disponibles.